-
Published07/11/2024
-
Today10/12/2024
-
Deadline11/12/2024
Utilities
Framework contract for RSV vaccines
Joint procurement for the RSV medicinal products was referred to in the Commission communication COM (2023)672 final, addressing medicine shortages in the EU, as a short-term or medium-term measure to improve availability of key antibiotics (in 2023-2024), by preventing lower respiratory tract disease (LRTD) caused by RSV
https://webgate.ec.europa.eu/digit/opsys/esubmission?cftUuid=d6cfe4ea-d103-4874-a8b5-1f9580966962
https://webgate.ec.europa.eu/digit/opsys/esubmission?cftUuid=d6cfe4ea-d103-4874-a8b5-1f9580966962
Type: quality
Description: Please consult the procurement documents.
Weight (percentage, exact): 60
Criterion:
Type: price
Description: Please consult the procurement documents.
Weight (percentage, exact): 40
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.